Literature DB >> 10458611

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

L Lin1, J Faraco, R Li, H Kadotani, W Rogers, X Lin, X Qiu, P J de Jong, S Nishino, E Mignot.   

Abstract

Narcolepsy is a disabling sleep disorder affecting humans and animals. It is characterized by daytime sleepiness, cataplexy, and striking transitions from wakefulness into rapid eye movement (REM) sleep. In this study, we used positional cloning to identify an autosomal recessive mutation responsible for this sleep disorder in a well-established canine model. We have determined that canine narcolepsy is caused by disruption of the hypocretin (orexin) receptor 2 gene (Hcrtr2). This result identifies hypocretins as major sleep-modulating neurotransmitters and opens novel potential therapeutic approaches for narcoleptic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458611     DOI: 10.1016/s0092-8674(00)81965-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  628 in total

1.  Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep.

Authors:  E Pinzar; Y Kanaoka; T Inui; N Eguchi; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 3.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 4.  The sleepy patient.

Authors:  N J Douglas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

Review 5.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

6.  What we learned from narcolepsy of others.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-02       Impact factor: 4.599

7.  Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons.

Authors:  Lior Appelbaum; Gordon Wang; Tohei Yokogawa; Gemini M Skariah; Stephen J Smith; Philippe Mourrain; Emmanuel Mignot
Journal:  Neuron       Date:  2010-10-06       Impact factor: 17.173

8.  Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

9.  Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle.

Authors:  Jerome Clasadonte; Eliana Scemes; Zhongya Wang; Detlev Boison; Philip G Haydon
Journal:  Neuron       Date:  2017-08-31       Impact factor: 17.173

10.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.